Copyright: ©Author(s) 2026.
World J Radiol. Jul 28, 2026; 18(7): 122165
Published online Jul 28, 2026. doi: 10.4329/wjr.122165
Published online Jul 28, 2026. doi: 10.4329/wjr.122165
Table 2 Comparative magnetic resonance imaging features of common benign and primary malignant small bowel neoplasms
| Category | Lesion | MRI features |
| Benign | Adenoma | Small, well-defined, intraluminal soft-tissue lesion, usually < 2 cm, with moderate enhancement |
| Lipoma | Signal intensity identical to fat, hyperintense on T1 and T2, with signal loss on fat-suppressed sequences | |
| Hemangioma | T2 hyperintense and enhancing; cavernous subtypes may appear polypoid or submucosal | |
| Leiomyoma | Well-circumscribed, submucosal smooth-muscle tumor; homogeneous focal mass with uniform enhancement greater than adjacent bowel | |
| Malignant | Adenocarcinoma | Annular or constricting lesion narrowing the lumen, often with irregular wall thickening and obstruction |
| Neuroendocrine tumor | Hyperenhancing primary lesion; often isointense to adjacent musculature on T1 and isointense to mildly hyperintense on T2; may be associated with a mesenteric mass or desmoplastic reaction | |
| GIST | Exophytic, heterogeneously enhancing mass that may demonstrate necrosis or hemorrhage | |
| Lymphoma | Variable appearance, including long-segment involvement and aneurysmal dilatation; splenomegaly and lymphadenopathy may support the diagnosis |
- Citation: Gonzalez Baerga CI, Menendez Santos M, Ortiz Cordero RG, Guevara Tirado OA, Virarkar M, Gopireddy DR. Role of magnetic resonance in bowel pathologies: Beyond inflammatory bowel disease. World J Radiol 2026; 18(7): 122165
- URL: https://www.wjgnet.com/1949-8470/full/v18/i7/122165.htm
- DOI: https://dx.doi.org/10.4329/wjr.122165